Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Nidec Copal

ACMOS

黒田精工

長野計器

Fujipream

NIDEC SANKYO CORPORATION　

IMV

大和製衡

Hitachi Medical

Rigaku

KOKUSAI

RHYTHM WATCH

CHINO

Precision Sysem Science

大日本スクリーン製造

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

PIONEER

クラリオン

クラリオン

クラリオン

クラリオン

Financial Indicator Details: Kawasumi Laboratories (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: Kawasumi Laboratories (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	4.04% (-5.08%)	5.89% (-9.48%)	4.74% (-5.79%)	4.94% (1.19%)	2.94% (0.27%)
C/F margin (Industry Average)	12.53% (4.61%)	11.05% (5.96%)	11.21% (6.03%)	17.75% (6.39%)	11.90% (6.49%)
ROA (Industry Average)	3.13% (-3.87%)	4.47% (-4.13%)	3.69% (-2.15%)	3.70% (0.83%)	1.90% (0.49%)
ROE (Industry Average)	4.13% (-9.94%)	5.73% (-25.68%)	4.78% (8.95%)	4.59% (-16.23%)	2.33% (2.54%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	7.06% (-0.46%)	0.10% (-13.23%)	2.42% (1.39%)	7.24% (98.25%)
Sales growth (Industry Average)	- (-)	2.00% (-13.10%)	3.66% (16.93%)	-5.49% (6.11%)	-8.29% (-1.65%)
Net profit growth (Industry Average)	- (-)	48.65% (-19.19%)	-16.52% (194.08%)	-1.57% (-44.77%)	-45.43% (-9.00%)
Operating C/F growth (Industry Average)	- (-)	-10.03% (125.18%)	5.13% (25.49%)	49.59% (9.71%)	-38.51% (232.01%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	75.79% (55.35%)	77.89% (54.43%)	77.11% (53.76%)	80.52% (55.27%)	81.22% (55.38%)
Liquidity ratio (Industry Average)	374.58% (259.99%)	360.22% (250.69%)	335.35% (276.19%)	437.37% (285.74%)	426.16% (300.76%)
C/F ratio current liabilities (Industry Average)	171.28% (369.78%)	190.86% (400.56%)	191.83% (255.68%)	103.21% (2,833.16%)	170.92% (230.73%)
Quick ratio (Industry Average)	272.91% (173.18%)	258.19% (169.67%)	235.62% (186.16%)	328.99% (196.65%)	299.38% (201.15%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	90.50day (89.35day)	95.78day (99.94day)	93.41day (90.85day)	99.51day (92.99day)	102.28day (97.80day)
Inventory turnover (Industry Average)	65.68day (69.13day)	67.73day (81.63day)	66.53day (89.49day)	63.31day (71.12day)	84.04day (82.23day)
Payable turnover (Industry Average)	35.34day (40.66day)	41.64day (55.57day)	39.02day (51.52day)	39.46day (45.05day)	33.36day (47.38day)
Working capita turnover (Industry Average)	120.84day (117.82day)	121.87day (126.00day)	120.92day (128.82day)	123.36day (119.06day)	152.96day (132.65day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	28.23% (44.01%)	-18.32% (19.29%)	-14.08% (-2.79%)	27.12% (20.66%)
Dividend Yield (Industry Average)	2.72% (3.25%)	2.11% (1.41%)	2.60% (1.25%)	3.04% (1.61%)	2.38% (1.57%)
PER (Industry Average)	10.25% (-8.47%)	8.84% (25.87%)	8.65% (21.27%)	7.55% (13.28%)	17.59% (22.53%)
PBR (Industry Average)	0.42% (0.81%)	0.50% (1.18%)	0.41% (1.36%)	0.34% (1.21%)	0.41% (1.24%)
PCFR (Industry Average)	3.30% (6.33%)	4.71% (8.84%)	3.66% (7.36%)	2.10% (36.13%)	4.35% (10.35%)
PSR (Industry Average)	0.41% (0.56%)	0.52% (0.80%)	0.41% (0.89%)	0.37% (0.79%)	0.51% (1.06%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	2.40% (-183.05%)	4.60% (-166,224.70%)	4.47% (-115.20%)	2.08% (-170.94%)	3.35% (-0.03%)
C/F margin (Industry Average)	- (-20.10%)	- (-7.51%)	- (-2.43%)	- (-3.06%)	- (-1.36%)
ROA (Industry Average)	2.07% (-7.87%)	4.02% (-7.01%)	3.73% (-6.26%)	1.77% (-3.03%)	2.53% (-0.36%)
ROE (Industry Average)	2.78% (-16.75%)	5.22% (-17.18%)	5.04% (32.87%)	2.22% (-6.83%)	3.21% (5.45%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	5.17% (-2.96%)	3.18% (-0.43%)	0.33% (-7.17%)	2.72% (12.76%)
Sales growth (Industry Average)	- (-)	3.20% (2.80%)	2.70% (12.49%)	-5.27% (6.17%)	-7.57% (26.85%)
Net profit growth (Industry Average)	- (-)	97.41% (-7,468.65%)	-0.36% (69.28%)	-55.73% (7.85%)	48.18% (-17.35%)
Operating C/F growth (Industry Average)	- (-)	- (-136.40%)	- (1,462.22%)	- (28.50%)	- (141.61%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	74.52% (58.33%)	77.00% (58.27%)	74.05% (56.06%)	79.80% (54.98%)	78.88% (56.81%)
Liquidity ratio (Industry Average)	336.80% (434.78%)	327.60% (290.28%)	272.09% (350.75%)	387.19% (559.70%)	- (461.82%)
C/F ratio current liabilities (Industry Average)	- (45.55%)	- (-120.18%)	- (-7.69%)	- (0.78%)	- (6.87%)
Quick ratio (Industry Average)	235.91% (307.75%)	230.85% (196.10%)	195.77% (235.82%)	289.01% (316.92%)	- (269.66%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	91.87day (88.94day)	95.49day (107.55day)	94.50day (96.21day)	98.30day (91.10day)	- (57.98day)
Inventory turnover (Industry Average)	50.81day (83.89day)	53.66day (63.66day)	51.62day (72.59day)	47.89day (51.80day)	- (39.78day)
Payable turnover (Industry Average)	33.79day (47.68day)	41.69day (56.31day)	51.57day (50.95day)	37.67day (43.94day)	- (26.54day)
Working capita turnover (Industry Average)	108.89day (125.16day)	107.47day (114.90day)	94.54day (117.85day)	108.52day (98.95day)	- (71.23day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	28.23% (49.67%)	-18.32% (16.73%)	-14.08% (-3.03%)	27.12% (23.13%)
Dividend Yield (Industry Average)	- (0.16%)	- (0.09%)	- (0.08%)	- (0.08%)	- (0.05%)
PER (Industry Average)	18.10% (-287.07%)	11.75% (15.35%)	9.63% (23.93%)	18.70% (28.68%)	16.04% (4.24%)
PBR (Industry Average)	0.50% (0.99%)	0.61% (1.46%)	0.48% (1.64%)	0.41% (1.58%)	0.51% (1.59%)
PCFR (Industry Average)	- (3.52%)	- (0.29%)	- (0.47%)	- (0.82%)	- (0.55%)
PSR (Industry Average)	0.43% (1.31%)	0.54% (1.94%)	0.43% (1.89%)	0.39% (3.03%)	0.53% (4.11%)

Financial Indicator Details: Kawasumi Laboratories

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	4.04%	5.89%	4.74%	4.94%	2.94%
C/F margin	12.53%	11.05%	11.21%	17.75%	11.90%
ROA	3.13%	4.47%	3.69%	3.70%	1.90%
ROE	4.13%	5.73%	4.78%	4.59%	2.33%
Recurring margin	7.69%	9.61%	7.62%	5.17%	2.97%
EBIT margin	4.95%	9.35%	7.60%	7.42%	4.78%
EBITDA margin	11.28%	15.71%	14.66%	15.38%	13.85%
NOPAT margin	2.97%	5.61%	4.56%	4.45%	2.87%
Sales SG rates	67.52%	64.91%	66.75%	69.08%	69.31%
Sales SG&A rates	25.02%	25.83%	25.85%	26.09%	29.18%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	6.33%	6.36%	7.06%	7.95%	9.06%
Capital expenditures net sales ratio	-5.85%	-10.43%	-8.60%	-10.17%	-15.10%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-14.78%	-7.88%	24.30%	-8.67%
Equity growth	-	7.06%	0.10%	2.42%	7.24%
Total assets growth	-	4.18%	1.11%	-1.90%	6.32%
Sales growth	-	2.00%	3.66%	-5.49%	-8.29%
Net profit growth	-	48.65%	-16.52%	-1.57%	-45.43%
Operating C/F growth	-	-10.03%	5.13%	49.59%	-38.51%
Recurring profit growth	-	27.37%	-17.83%	-35.83%	-47.26%
EBIT growth	-	92.49%	-15.70%	-7.69%	-40.86%
EBITDA growth	-	42.03%	-3.26%	-0.87%	-17.39%
NOPAT growth	-	92.49%	-15.70%	-7.69%	-40.86%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	75.79%	77.89%	77.11%	80.52%	81.22%
Liquidity ratio	374.58%	360.22%	335.35%	437.37%	426.16%
C/F ratio current liabilities	171.28%	190.86%	191.83%	103.21%	170.92%
Quick ratio	272.91%	258.19%	235.62%	328.99%	299.38%
Fixed ratio	36.35%	40.39%	44.03%	39.19%	44.68%
D/E ratio	3.45%	1.65%	-	-	-
Loan to Value Ratio	2.61%	1.29%	-	-	-
Business investment C/F ratio	-46.70%	-94.39%	-76.75%	-57.30%	-126.93%
Liabilities with interest growth	-	-48.58%	-100.00%	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	123.40day	103.09day	91.60day	120.49day	119.99day
Receivables turnover	90.50day	95.78day	93.41day	99.51day	102.28day
Inventory turnover	65.68day	67.73day	66.53day	63.31day	84.04day
Fixed assets turnover	129.90day	151.52day	159.47day	153.84day	205.15day
Total asset turnover	471.43day	481.50day	469.65day	487.47day	565.16day
Payable turnover	35.34day	41.64day	39.02day	39.46day	33.36day
Capital turnover	79.83day	78.26day	75.49day	79.88day	87.11day
Equity turnover	357.33day	375.06day	362.19day	392.53day	459.06day
Working capita turnover	120.84day	121.87day	120.92day	123.36day	152.96day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 10 B	¥ 8 B	¥ 8 B	¥ 10 B	¥ 9 B
Accounts receivable-trade	¥ 7 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 7 B
Other Current Assets	¥ 14 B	¥ 14 B	¥ 15 B	¥ 14 B	¥ 14 B
Current Assets	¥ 24 B	¥ 23 B	¥ 23 B	¥ 24 B	¥ 24 B
Tangible Assets	¥ 10 B	¥ 12 B	¥ 14 B	¥ 12 B	¥ 15 B
Intangible Assets	¥ 737 M	¥ 1 B	¥ 807 M	¥ 582 M	¥ 411 M
Investment etc.	¥ 3 B	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B
Total Assets	¥ 39 B	¥ 40 B	¥ 41 B	¥ 40 B	¥ 43 B
Current Liabilities	¥ 6 B	¥ 6 B	¥ 6 B	¥ 5 B	¥ 5 B
Fixed Liabilities	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Liabilities with interest	¥ 1 B	¥ 528 M	-	-	-
Net Assets	¥ 29 B	¥ 31 B	¥ 31 B	¥ 32 B	¥ 35 B
Capital stock	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Capital surplus etc.	¥ 23 B	¥ 25 B	¥ 25 B	¥ 25 B	¥ 28 B
Liabilities and net assets	¥ 39 B	¥ 40 B	¥ 41 B	¥ 40 B	¥ 43 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 30 B	¥ 30 B	¥ 32 B	¥ 30 B	¥ 27 B
Cost of Sales	¥ 20 B	¥ 20 B	¥ 21 B	¥ 20 B	¥ 19 B
Gross profit	¥ 9 B	¥ 10 B	¥ 10 B	¥ 9 B	¥ 8 B
Other income	¥ 443 M	¥ 452 M	¥ 547 M	¥ 3 B	¥ 1 B
SG&A	¥ 7 B	¥ 8 B	¥ 8 B	¥ 7 B	¥ 8 B
Other expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 3 B	¥ 1 B
Net income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 819 M
Operating income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 1 B	¥ 419 M
Ordinary Income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 1 B	¥ 828 M
EBITDA	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 3 B
Income before income taxes	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 1 B
Depreciation	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 235 M	¥ 1 B	¥ 884 M	¥ 738 M	¥ 497 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 3 B	¥ 3 B	¥ 3 B	¥ 5 B	¥ 3 B
Investment CF	¥ -2 B	¥ -4 B	¥ -2 B	¥ -3 B	¥ -4 B
Financial CF	¥ -1 B	¥ -909 M	¥ -902 M	¥ -366 M	¥ -368 M
Foreign Exchange Effects	¥ -395 M	¥ 50 M	¥ -76 M	¥ 49 M	¥ 403 M
Net Change in Cash	¥ -147 M	¥ -1 B	¥ -343 M	¥ 1 B	¥ -870 M
Free CF	¥ 1 B	¥ -619 M	¥ 636 M	¥ 2 B	¥ -905 M
Capital expenditures	¥ -1 B	¥ -3 B	¥ -2 B	¥ -3 B	¥ -4 B
Cash dividends paid	¥ -343 M	¥ -341 M	¥ -344 M	¥ -345 M	¥ -344 M
Repayment loans	¥ -529 M	¥ -500 M	¥ -527 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -343 M	¥ -343 M	¥ -343 M	¥ -343 M	¥ -343 M
Net income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 819 M
Purchase of treasury stock	¥ -3 M	¥ -4 M	¥ -4 M	-	-
Other Change in Stockholders Equity	-	¥ -1 M	¥ -1 M	¥ -1 M	-
Other Change in Net Assets	¥ -1 B	¥ 621 M	¥ -1 B	¥ -386 M	¥ 1 B
Net Change in Net Assets	¥ -822 M	¥ 2 B	¥ 34 M	¥ 771 M	¥ 2 B

Financial Indicator Details: Kawasumi Laboratories

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	2.40%	4.60%	4.47%	2.08%	3.35%
C/F margin	-	-	-	-	-
ROA	2.07%	4.02%	3.73%	1.77%	2.53%
ROE	2.78%	5.22%	5.04%	2.22%	3.21%
Recurring margin	5.80%	7.80%	7.21%	4.97%	5.64%
EBIT margin	3.01%	7.52%	7.13%	3.73%	-
EBITDA margin	3.14%	7.64%	7.15%	3.90%	-
NOPAT margin	1.80%	4.51%	4.27%	2.23%	-
Sales SG rates	71.86%	69.88%	69.13%	71.06%	96.64%
Sales SG&A rates	23.20%	23.60%	24.47%	24.95%	-
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	0.13%	0.12%	0.01%	0.16%	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-16.89%	17.09%	-5.73%	-100.00%
Equity growth	-	5.17%	3.18%	0.33%	2.72%
Total assets growth	-	1.79%	7.29%	-6.89%	3.91%
Sales growth	-	3.20%	2.70%	-5.27%	-7.57%
Net profit growth	-	97.41%	-0.36%	-55.73%	48.18%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	38.61%	-5.03%	-34.72%	4.85%
EBIT growth	-	157.81%	-2.67%	-50.43%	-100.00%
EBITDA growth	-	150.71%	-3.94%	-48.33%	-100.00%
NOPAT growth	-	157.81%	-2.67%	-50.43%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	74.52%	77.00%	74.05%	79.80%	78.88%
Liquidity ratio	336.80%	327.60%	272.09%	387.19%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	235.91%	230.85%	195.77%	289.01%	-
Fixed ratio	27.39%	25.87%	31.27%	29.84%	-
D/E ratio	4.00%	1.90%	-	-	-
Loan to Value Ratio	2.98%	1.46%	-	-	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-50.00%	-100.00%	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	88.94day	71.62day	81.66day	81.26day	-
Receivables turnover	91.87day	95.49day	94.50day	98.30day	-
Inventory turnover	50.81day	53.66day	51.62day	47.89day	-
Fixed assets turnover	86.53day	83.30day	101.15day	102.25day	-
Total asset turnover	423.83day	418.06day	436.75day	429.30day	482.64day
Payable turnover	33.79day	41.69day	51.57day	37.67day	-
Capital turnover	83.93day	81.33day	79.19day	83.60day	-
Equity turnover	315.87day	321.92day	323.44day	342.59day	380.75day
Working capita turnover	108.89day	107.47day	94.54day	108.52day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 7 B	¥ 5 B	¥ 6 B	¥ 6 B	-
Accounts receivable-trade	¥ 7 B	¥ 7 B	¥ 7 B	-	-
Other Current Assets	¥ 13 B	¥ 13 B	¥ 13 B	¥ 12 B	-
Current Assets	¥ 20 B	¥ 19 B	¥ 20 B	-	-
Tangible Assets	¥ 6 B	¥ 6 B	¥ 8 B	¥ 8 B	-
Intangible Assets	¥ 719 M	¥ 1 B	¥ 795 M	¥ 575 M	-
Investment etc.	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 35 B
Total Assets	¥ 33 B	¥ 34 B	¥ 36 B	¥ 34 B	¥ 35 B
Current Liabilities	¥ 6 B	¥ 5 B	¥ 7 B	¥ 4 B	¥ 7 B
Fixed Liabilities	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	-
Liabilities with interest	¥ 1 B	¥ 500 M	-	-	-
Net Assets	¥ 24 B	¥ 26 B	¥ 27 B	¥ 27 B	¥ 27 B
Capital stock	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	-
Capital surplus etc.	¥ 18 B	¥ 19 B	¥ 20 B	¥ 20 B	¥ 27 B
Liabilities and net assets	¥ 33 B	¥ 34 B	¥ 36 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 28 B	¥ 29 B	¥ 30 B	¥ 28 B	¥ 26 B
Cost of Sales	¥ 20 B	¥ 20 B	¥ 21 B	¥ 20 B	¥ 25 B
Gross profit	¥ 8 B	¥ 8 B	¥ 9 B	¥ 8 B	¥ 898 M
Other income	¥ 518 M	¥ 684 M	¥ 655 M	¥ 453 M	-
SG&A	¥ 6 B	¥ 7 B	¥ 7 B	¥ 7 B	-
Other expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 998 M	-
Net income	¥ 696 M	¥ 1 B	¥ 1 B	¥ 606 M	¥ 898 M
Operating income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Ordinary Income	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B	¥ 1 B
EBITDA	¥ 909 M	¥ 2 B	¥ 2 B	¥ 1 B	-
Income before income taxes	¥ 864 M	¥ 2 B	¥ 2 B	-	-
Depreciation	¥ 39 M	¥ 36 M	¥ 6 M	¥ 49 M	-
R&D expenses	-	-	-	-	-
Income taxes	¥ 167 M	¥ 875 M	¥ 822 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -343 M	¥ -343 M	¥ -343 M	-	-
Net income	¥ 696 M	¥ 1 B	¥ 1 B	-	-
Purchase of treasury stock	¥ -3 M	¥ -4 M	¥ -4 M	-	-
Other Change in Stockholders Equity	¥ -1 M	¥ -1 M	¥ -2 M	-	-
Other Change in Net Assets	¥ -233 M	¥ 268 M	¥ -183 M	-	-
Net Change in Net Assets	¥ 116 M	¥ 1 B	¥ 837 M	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Kawasumi Laboratories (Annual )

Statement Type

Annual : Kawasumi Laboratories

First quarter : Kawasumi Laboratories

Second quarter : Kawasumi Laboratories

Third quarter : Kawasumi Laboratories

Analysis Menu

Outline : Kawasumi Laboratories

Statement : Kawasumi Laboratories

Rating : Kawasumi Laboratories

Indicator : Kawasumi Laboratories

Download : Kawasumi Laboratories

Industry Comparison Ranking

Precision Instruments - EDIUNET Industry Rankings

Precision Instruments - EDIUNET Credit Rating

Precision Instruments - EDIUNET Industry Avg

Comparison with a neighboring company

Oita - EDIUNET Prefectures

Oita佐伯市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/15	シグマ光機	BBB	2013-11-30 (Q2)
1/15	RORZE	B→BB	2013-11-30 (Q3)
1/9	スター精密	BB	2013-11-30 (Q3)
1/7	マニー	AA	2013-11-30 (Q1)
12/13	インスペック	C	2013-10-31 (Q2)
12/5	三井ハイテック	A→AA	2013-10-31 (Q3)
12/5	アルチザネットワークス	BB→BBB	2013-10-31 (Q1)
11/14	asahi intecc	BBB→A	2013-09-30 (Q1)
11/14	黒田精工	B→CCC	2013-09-30 (Q2)
11/14	Precision Sysem Science	CCC→BBB	2013-09-30 (Q1)

EDIUNET Investment News (Precision Instruments)

1/15 Precision Instruments (シグ..

1/9 Precision Instruments (スタ..

1/7 Precision Instruments (マニ..

12/13 Precision Instruments (イン..

12/5 Precision Instruments (三井..

11/14 Precision Instruments (asahi..

11/13 Precision Instruments (OVAL:..

11/12 Precision Instruments (SEIKO..

11/11 Precision Instruments (MORIT..

11/8 Precision Instruments (オリ..

Company Information

Ticker	Market	Industry	Month	report	Rating
Kawasumi Laboratories	7703	TSE 2st	Precision Instruments	3	Annual	AA

Related Company

V Technology (Sales ¥ 3 B)

NIDEC SANKYO CORPORATION　 (Sales ¥ 81 B)

Rigaku (Sales ¥ 31 B)

IMV (Sales ¥ 6 B)

Nihon Seimitsu (Sales ¥ 5 B)

sekonic holdings (Sales ¥ 10 B)

ACMOS (Sales ¥ 2 B)

RHYTHM WATCH (Sales ¥ 32 B)

大和製衡 (Sales ¥ 18 B)

CHINO (Sales ¥ 17 B)

Hitachi Medical (Sales ¥ 159 B)

KOKUSAI (Sales ¥ 10 B)

TOKYO KEIKI (Sales ¥ 40 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .